ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meloxicam Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-8T17320
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Meloxicam Tablets Market Research Report 2024
BUY CHAPTERS

Global Meloxicam Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-8T17320
Report
November 2025
Pages:160
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical
Lupin Ltd
Apotex
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Qilu Pharmaceutical
Yangtze River Pharmaceutical
Zhejiang Xianju Pharmaceutical
Youcare Pharmaceutical

Meloxicam Tablets Market

The global Meloxicam Tablets market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Rheumatoid Arthritis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Meloxicam Tablets leading manufacturers including Boehringer Ingelheim, Mylan, Teva Pharmaceutical, Lupin, Apotex, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Boehringer Ingelheim leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Meloxicam Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Meloxicam Tablets Market Report

Report Metric Details
Report Name Meloxicam Tablets Market
Segment by Type
  • Original Drug
  • Generic Drug
Segment by Application
  • Rheumatoid Arthritis
  • Osteoarthritis
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Mylan, Teva Pharmaceutical, Lupin, Apotex, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, Youcare Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Meloxicam Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Meloxicam Tablets Market report?

Ans: The main players in the Meloxicam Tablets Market are Boehringer Ingelheim, Mylan, Teva Pharmaceutical, Lupin, Apotex, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, Youcare Pharmaceutical

What are the Application segmentation covered in the Meloxicam Tablets Market report?

Ans: The Applications covered in the Meloxicam Tablets Market report are Rheumatoid Arthritis, Osteoarthritis

What are the Type segmentation covered in the Meloxicam Tablets Market report?

Ans: The Types covered in the Meloxicam Tablets Market report are Original Drug, Generic Drug

1 Study Coverage
1.1 Introduction to Meloxicam Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Meloxicam Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market Segmentation by Application
1.3.1 Global Meloxicam Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Meloxicam Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Meloxicam Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Meloxicam Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Meloxicam Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Meloxicam Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Meloxicam Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Original Drug Market Size by Manufacturers
3.5.2 Generic Drug Market Size by Manufacturers
3.6 Global Meloxicam Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Meloxicam Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Meloxicam Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Meloxicam Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Meloxicam Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Meloxicam Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Meloxicam Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Meloxicam Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Meloxicam Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Meloxicam Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Meloxicam Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Meloxicam Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Meloxicam Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Meloxicam Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Meloxicam Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Meloxicam Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Meloxicam Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Meloxicam Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Meloxicam Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Meloxicam Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Meloxicam Tablets Product Models, Descriptions and Specifications
11.1.4 Boehringer Ingelheim Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boehringer Ingelheim Meloxicam Tablets Sales by Product in 2024
11.1.6 Boehringer Ingelheim Meloxicam Tablets Sales by Application in 2024
11.1.7 Boehringer Ingelheim Meloxicam Tablets Sales by Geographic Area in 2024
11.1.8 Boehringer Ingelheim Meloxicam Tablets SWOT Analysis
11.1.9 Boehringer Ingelheim Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Business Overview
11.2.3 Mylan Meloxicam Tablets Product Models, Descriptions and Specifications
11.2.4 Mylan Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Mylan Meloxicam Tablets Sales by Product in 2024
11.2.6 Mylan Meloxicam Tablets Sales by Application in 2024
11.2.7 Mylan Meloxicam Tablets Sales by Geographic Area in 2024
11.2.8 Mylan Meloxicam Tablets SWOT Analysis
11.2.9 Mylan Recent Developments
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Corporation Information
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Meloxicam Tablets Product Models, Descriptions and Specifications
11.3.4 Teva Pharmaceutical Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Teva Pharmaceutical Meloxicam Tablets Sales by Product in 2024
11.3.6 Teva Pharmaceutical Meloxicam Tablets Sales by Application in 2024
11.3.7 Teva Pharmaceutical Meloxicam Tablets Sales by Geographic Area in 2024
11.3.8 Teva Pharmaceutical Meloxicam Tablets SWOT Analysis
11.3.9 Teva Pharmaceutical Recent Developments
11.4 Lupin
11.4.1 Lupin Corporation Information
11.4.2 Lupin Business Overview
11.4.3 Lupin Meloxicam Tablets Product Models, Descriptions and Specifications
11.4.4 Lupin Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Lupin Meloxicam Tablets Sales by Product in 2024
11.4.6 Lupin Meloxicam Tablets Sales by Application in 2024
11.4.7 Lupin Meloxicam Tablets Sales by Geographic Area in 2024
11.4.8 Lupin Meloxicam Tablets SWOT Analysis
11.4.9 Lupin Recent Developments
11.5 Apotex
11.5.1 Apotex Corporation Information
11.5.2 Apotex Business Overview
11.5.3 Apotex Meloxicam Tablets Product Models, Descriptions and Specifications
11.5.4 Apotex Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Apotex Meloxicam Tablets Sales by Product in 2024
11.5.6 Apotex Meloxicam Tablets Sales by Application in 2024
11.5.7 Apotex Meloxicam Tablets Sales by Geographic Area in 2024
11.5.8 Apotex Meloxicam Tablets SWOT Analysis
11.5.9 Apotex Recent Developments
11.6 Dr. Reddy's Laboratories
11.6.1 Dr. Reddy's Laboratories Corporation Information
11.6.2 Dr. Reddy's Laboratories Business Overview
11.6.3 Dr. Reddy's Laboratories Meloxicam Tablets Product Models, Descriptions and Specifications
11.6.4 Dr. Reddy's Laboratories Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Dr. Reddy's Laboratories Recent Developments
11.7 Glenmark Pharmaceuticals
11.7.1 Glenmark Pharmaceuticals Corporation Information
11.7.2 Glenmark Pharmaceuticals Business Overview
11.7.3 Glenmark Pharmaceuticals Meloxicam Tablets Product Models, Descriptions and Specifications
11.7.4 Glenmark Pharmaceuticals Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Glenmark Pharmaceuticals Recent Developments
11.8 Qilu Pharmaceutical
11.8.1 Qilu Pharmaceutical Corporation Information
11.8.2 Qilu Pharmaceutical Business Overview
11.8.3 Qilu Pharmaceutical Meloxicam Tablets Product Models, Descriptions and Specifications
11.8.4 Qilu Pharmaceutical Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Qilu Pharmaceutical Recent Developments
11.9 Yangtze River Pharmaceutical
11.9.1 Yangtze River Pharmaceutical Corporation Information
11.9.2 Yangtze River Pharmaceutical Business Overview
11.9.3 Yangtze River Pharmaceutical Meloxicam Tablets Product Models, Descriptions and Specifications
11.9.4 Yangtze River Pharmaceutical Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Yangtze River Pharmaceutical Recent Developments
11.10 Zhejiang Xianju Pharmaceutical
11.10.1 Zhejiang Xianju Pharmaceutical Corporation Information
11.10.2 Zhejiang Xianju Pharmaceutical Business Overview
11.10.3 Zhejiang Xianju Pharmaceutical Meloxicam Tablets Product Models, Descriptions and Specifications
11.10.4 Zhejiang Xianju Pharmaceutical Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Zhejiang Xianju Pharmaceutical Recent Developments
11.11 Youcare Pharmaceutical
11.11.1 Youcare Pharmaceutical Corporation Information
11.11.2 Youcare Pharmaceutical Business Overview
11.11.3 Youcare Pharmaceutical Meloxicam Tablets Product Models, Descriptions and Specifications
11.11.4 Youcare Pharmaceutical Meloxicam Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Youcare Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Meloxicam Tablets Industry Chain
12.2 Meloxicam Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Meloxicam Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Meloxicam Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Meloxicam Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Meloxicam Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Teva Pharmaceutical
Lupin Ltd
Apotex
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Qilu Pharmaceutical
Yangtze River Pharmaceutical
Zhejiang Xianju Pharmaceutical
Youcare Pharmaceutical
List of Tables
 Table 1. Global Meloxicam Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Meloxicam Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Meloxicam Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Meloxicam Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Meloxicam Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Meloxicam Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Meloxicam Tablets Sales by Region (2020-2025) & (K Units)
 Table 8. Global Meloxicam Tablets Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Meloxicam Tablets Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Meloxicam Tablets Sales Share by Manufacturers (2020-2025)
 Table 12. Global Meloxicam Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Meloxicam Tablets Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Meloxicam Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam Tablets as of 2024)
 Table 16. Global Meloxicam Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Meloxicam Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Meloxicam Tablets Manufacturing Base and Headquarters
 Table 19. Global Meloxicam Tablets Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Meloxicam Tablets Sales by Type (2020-2025) & (K Units)
 Table 23. Global Meloxicam Tablets Sales by Type (2026-2031) & (K Units)
 Table 24. Global Meloxicam Tablets Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Meloxicam Tablets Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Meloxicam Tablets ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Meloxicam Tablets Sales by Application (2020-2025) & (K Units)
 Table 29. Global Meloxicam Tablets Sales by Application (2026-2031) & (K Units)
 Table 30. Meloxicam Tablets High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Meloxicam Tablets Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Meloxicam Tablets Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Meloxicam Tablets ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Meloxicam Tablets Growth Accelerators and Market Barriers
 Table 37. North America Meloxicam Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Meloxicam Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Meloxicam Tablets Growth Accelerators and Market Barriers
 Table 40. Europe Meloxicam Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Meloxicam Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Meloxicam Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Meloxicam Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Meloxicam Tablets Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Meloxicam Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Meloxicam Tablets Investment Opportunities and Key Challenges
 Table 47. Central and South America Meloxicam Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Meloxicam Tablets Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Meloxicam Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Boehringer Ingelheim Corporation Information
 Table 51. Boehringer Ingelheim Description and Major Businesses
 Table 52. Boehringer Ingelheim Product Models, Descriptions and Specifications
 Table 53. Boehringer Ingelheim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Boehringer Ingelheim Sales Value Proportion by Product in 2024
 Table 55. Boehringer Ingelheim Sales Value Proportion by Application in 2024
 Table 56. Boehringer Ingelheim Sales Value Proportion by Geographic Area in 2024
 Table 57. Boehringer Ingelheim Meloxicam Tablets SWOT Analysis
 Table 58. Boehringer Ingelheim Recent Developments
 Table 59. Mylan Corporation Information
 Table 60. Mylan Description and Major Businesses
 Table 61. Mylan Product Models, Descriptions and Specifications
 Table 62. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Mylan Sales Value Proportion by Product in 2024
 Table 64. Mylan Sales Value Proportion by Application in 2024
 Table 65. Mylan Sales Value Proportion by Geographic Area in 2024
 Table 66. Mylan Meloxicam Tablets SWOT Analysis
 Table 67. Mylan Recent Developments
 Table 68. Teva Pharmaceutical Corporation Information
 Table 69. Teva Pharmaceutical Description and Major Businesses
 Table 70. Teva Pharmaceutical Product Models, Descriptions and Specifications
 Table 71. Teva Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Teva Pharmaceutical Sales Value Proportion by Product in 2024
 Table 73. Teva Pharmaceutical Sales Value Proportion by Application in 2024
 Table 74. Teva Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 75. Teva Pharmaceutical Meloxicam Tablets SWOT Analysis
 Table 76. Teva Pharmaceutical Recent Developments
 Table 77. Lupin Corporation Information
 Table 78. Lupin Description and Major Businesses
 Table 79. Lupin Product Models, Descriptions and Specifications
 Table 80. Lupin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Lupin Sales Value Proportion by Product in 2024
 Table 82. Lupin Sales Value Proportion by Application in 2024
 Table 83. Lupin Sales Value Proportion by Geographic Area in 2024
 Table 84. Lupin Meloxicam Tablets SWOT Analysis
 Table 85. Lupin Recent Developments
 Table 86. Apotex Corporation Information
 Table 87. Apotex Description and Major Businesses
 Table 88. Apotex Product Models, Descriptions and Specifications
 Table 89. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Apotex Sales Value Proportion by Product in 2024
 Table 91. Apotex Sales Value Proportion by Application in 2024
 Table 92. Apotex Sales Value Proportion by Geographic Area in 2024
 Table 93. Apotex Meloxicam Tablets SWOT Analysis
 Table 94. Apotex Recent Developments
 Table 95. Dr. Reddy's Laboratories Corporation Information
 Table 96. Dr. Reddy's Laboratories Description and Major Businesses
 Table 97. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications
 Table 98. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Dr. Reddy's Laboratories Recent Developments
 Table 100. Glenmark Pharmaceuticals Corporation Information
 Table 101. Glenmark Pharmaceuticals Description and Major Businesses
 Table 102. Glenmark Pharmaceuticals Product Models, Descriptions and Specifications
 Table 103. Glenmark Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Glenmark Pharmaceuticals Recent Developments
 Table 105. Qilu Pharmaceutical Corporation Information
 Table 106. Qilu Pharmaceutical Description and Major Businesses
 Table 107. Qilu Pharmaceutical Product Models, Descriptions and Specifications
 Table 108. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Qilu Pharmaceutical Recent Developments
 Table 110. Yangtze River Pharmaceutical Corporation Information
 Table 111. Yangtze River Pharmaceutical Description and Major Businesses
 Table 112. Yangtze River Pharmaceutical Product Models, Descriptions and Specifications
 Table 113. Yangtze River Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Yangtze River Pharmaceutical Recent Developments
 Table 115. Zhejiang Xianju Pharmaceutical Corporation Information
 Table 116. Zhejiang Xianju Pharmaceutical Description and Major Businesses
 Table 117. Zhejiang Xianju Pharmaceutical Product Models, Descriptions and Specifications
 Table 118. Zhejiang Xianju Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Zhejiang Xianju Pharmaceutical Recent Developments
 Table 120. Youcare Pharmaceutical Corporation Information
 Table 121. Youcare Pharmaceutical Description and Major Businesses
 Table 122. Youcare Pharmaceutical Product Models, Descriptions and Specifications
 Table 123. Youcare Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Youcare Pharmaceutical Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Meloxicam Tablets Product Picture
 Figure 2. Global Meloxicam Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Original Drug Product Picture
 Figure 4. Generic Drug Product Picture
 Figure 5. Global Meloxicam Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Rheumatoid Arthritis
 Figure 7. Osteoarthritis
 Figure 8. Meloxicam Tablets Report Years Considered
 Figure 9. Global Meloxicam Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Meloxicam Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Meloxicam Tablets Revenue Market Share by Region (2020-2031)
 Figure 13. Global Meloxicam Tablets Sales (2020-2031) & (K Units)
 Figure 14. Global Meloxicam Tablets Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Meloxicam Tablets Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Meloxicam Tablets Sales Volume Market Share in 2024
 Figure 17. Global Meloxicam Tablets Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Original Drug Revenue Market Share by Manufacturer in 2024
 Figure 20. Generic Drug Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Meloxicam Tablets Sales Market Share by Type (2020-2031)
 Figure 22. Global Meloxicam Tablets Revenue Market Share by Type (2020-2031)
 Figure 23. Global Meloxicam Tablets Sales Market Share by Application (2020-2031)
 Figure 24. Global Meloxicam Tablets Revenue Market Share by Application (2020-2031)
 Figure 25. North America Meloxicam Tablets Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Meloxicam Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Meloxicam Tablets Sales Revenue (US$ Million) in 2024
 Figure 28. North America Meloxicam Tablets Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Meloxicam Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Meloxicam Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Meloxicam Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Meloxicam Tablets Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Meloxicam Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Meloxicam Tablets Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Meloxicam Tablets Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Meloxicam Tablets Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Meloxicam Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Meloxicam Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 43. France Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Meloxicam Tablets Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Meloxicam Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Meloxicam Tablets Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Meloxicam Tablets Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Meloxicam Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Meloxicam Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Meloxicam Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 58. India Meloxicam Tablets Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Meloxicam Tablets Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Meloxicam Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Meloxicam Tablets Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Meloxicam Tablets Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Meloxicam Tablets Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Meloxicam Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Meloxicam Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Meloxicam Tablets Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Meloxicam Tablets Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Meloxicam Tablets Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Meloxicam Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Meloxicam Tablets Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Meloxicam Tablets Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Meloxicam Tablets Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Meloxicam Tablets Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Meloxicam Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Meloxicam Tablets Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Meloxicam Tablets Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Meloxicam Tablets Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Meloxicam Tablets Revenue (2020-2025) & (US$ Million)
 Figure 79. Meloxicam Tablets Industry Chain Mapping
 Figure 80. Regional Meloxicam Tablets Manufacturing Base Distribution (%)
 Figure 81. Global Meloxicam Tablets Production Market Share by Region (2020-2031)
 Figure 82. Meloxicam Tablets Production Process
 Figure 83. Regional Meloxicam Tablets Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Oral Meloxicam Market Research Report 2024
Global Meloxicam Capsules Market Research Report 2024
Meloxicam Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meloxicam Drugs Market Research Report 2024
Global Olmesartan Medoxomil Tablets Market Research Report 2024
Global Naproxen Tablets Market Research Report 2024
Global Cymoxanil Market Research Report 2024
Global Meloxicam Market Research Report 2024
Global Amodiaquine Tablets Market Research Report 2024
Global Melphalan Market Research Report 2024
Global Troxerutin Tablets Market Research Report 2024
Cefixime Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aceclofenac Tablets Market Research Report 2024
Global Synovitis Tablets Market Research Report 2024
Medical Grade Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nifedipine Tablets Market Research Report 2024
Global Adoxal Market Research Report 2024
Global Sitafloxacin Tablets Market Research Report 2024
Global Salicylaldoxime Market Research Report 2025
Global Olmesartan Medoxomil Amlodipine Tablets Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions